{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T19:33:14Z","timestamp":1783625594586,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T00:00:00Z","timestamp":1546732800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00277-018-03590-x","type":"journal-article","created":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T06:19:08Z","timestamp":1546755548000},"page":"647-656","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical and genetic characterization of de novo double-hit B cell precursor leukemia\/lymphoma"],"prefix":"10.1007","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7726-6622","authenticated-orcid":false,"given":"Jan A.","family":"Stratmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron Becker","family":"von Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Koschade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Wendelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Heinsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kilian","family":"Schiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Haferlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Wattad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Rieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Serve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"G\u00f6kbuget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Steffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,6]]},"reference":[{"issue":"20","key":"3590_CR1","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","volume":"28","author":"S Barrans","year":"2010","unstructured":"Barrans S, Crouch S, Smith A, Turner K, Owen R, Patmore R, Roman E, Jack A (2010) Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab. J Clin Oncol Off J Am Soc Clin Oncol 28(20):3360\u20133365. \n                    https:\/\/doi.org\/10.1200\/JCO.2009.26.3947","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"4","key":"3590_CR2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/leu.2008.344","volume":"23","author":"N Niitsu","year":"2009","unstructured":"Niitsu N, Okamoto M, Miura I, Hirano M (2009) Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24\/c-MYC translocations. Leukemia 23(4):777\u2013783. \n                    https:\/\/doi.org\/10.1038\/leu.2008.344","journal-title":"Leukemia"},{"issue":"19","key":"3590_CR3","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","volume":"117","author":"E Campo","year":"2011","unstructured":"Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES (2011) The 2008 WHO classification of lymphoid neoplasms and beyond. Evolving concepts and practical applications. Blood 117(19):5019\u20135032. \n                    https:\/\/doi.org\/10.1182\/blood-2011-01-293050","journal-title":"Blood"},{"issue":"6","key":"3590_CR4","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/bjh.12982","volume":"166","author":"Y Oki","year":"2014","unstructured":"Oki Y, Noorani M, Lin P, Davis RE, Neelapu SS, Ma L, Ahmed M, Rodriguez MA, Hagemeister FB, Fowler N, Wang M, Fanale MA, Nastoupil L, Samaniego F, Lee HJ, Dabaja BS, Pinnix CC, Medeiros LJ, Nieto Y, Khouri I, Kwak LW, Turturro F, Romaguera JE, Fayad LE, Westin JR (2014) Double hit lymphoma. The MD Anderson Cancer Center clinical experience. Br J Haematol 166(6):891\u2013901. \n                    https:\/\/doi.org\/10.1111\/bjh.12982","journal-title":"Br J Haematol"},{"issue":"20","key":"3590_CR5","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390. \n                    https:\/\/doi.org\/10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"issue":"2","key":"3590_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/modpathol.2017.134","volume":"31","author":"M Miyaoka","year":"2018","unstructured":"Miyaoka M, Kikuti YY, Carreras J, Ikoma H, Hiraiwa S, Ichiki A, Kojima M, Ando K, Yokose T, Sakai R, Hoshikawa M, Tomita N, Miura I, Takata K, Yoshino T, Takizawa J, Bea S, Campo E, Nakamura N (2018) Clinicopathological and genomic analysis of double-hit follicular lymphoma. Comparison with high-grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements. Mod Pathol 31(2):313\u2013326. \n                    https:\/\/doi.org\/10.1038\/modpathol.2017.134","journal-title":"Mod Pathol"},{"issue":"4","key":"3590_CR7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00428-017-2199-7","volume":"471","author":"L Rimsza","year":"2017","unstructured":"Rimsza L, Pittaluga S, Dirnhofer S, Copie-Bergman C, de Leval L, Facchetti F, Pileri S, Rosenwald A, Wotherspoon A, Fend F (2017) The clinicopathologic spectrum of mature aggressive B cell lymphomas. Virchows Arch 471(4):453\u2013466. \n                    https:\/\/doi.org\/10.1007\/s00428-017-2199-7","journal-title":"Virchows Arch"},{"issue":"2","key":"3590_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1182\/blood-2014-02-558833","volume":"124","author":"A Stengel","year":"2014","unstructured":"Stengel A, Schnittger S, Weissmann S, Kuznia S, Kern W, Kohlmann A, Haferlach T, Haferlach C (2014) TP53 mutations occur in 15.7% of ALL and are associated with MYC-rearrangement, low hypodiploidy, and a poor prognosis. Blood 124(2):251\u2013258. \n                    https:\/\/doi.org\/10.1182\/blood-2014-02-558833","journal-title":"Blood"},{"issue":"24","key":"3590_CR9","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1002\/cncr.28950","volume":"120","author":"C Motll\u00f3","year":"2014","unstructured":"Motll\u00f3 C, Ribera J-M, Morgades M, Granada I, Montesinos P, Gonz\u00e1lez-Campos J, Fern\u00e1ndez-Abell\u00e1n P, Tormo M, Bethencourt C, Brunet S, Hern\u00e1ndez-Rivas JM, Moreno MJ, Sarr\u00e0 J, del Potro E, Barba P, Bernal T, Grande C, Grau J, Cervera J, Feliu E, PETHEMA Group, Spanish Society of Hematology (2014) Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols. Cancer 120(24):3958\u20133964. \n                    https:\/\/doi.org\/10.1002\/cncr.28950","journal-title":"Cancer"},{"issue":"1","key":"3590_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1365-2141.2001.02643.x","volume":"113","author":"CJ Harrison","year":"2001","unstructured":"Harrison CJ, Martineau M, Secker-Walker LM (2001) The Leukaemia Research Fund\/United Kingdom Cancer Cytogenetics Group Karyotype Database in acute lymphoblastic leukaemia. A valuable resource for patient management. Br J Haematol 113(1):3\u201310","journal-title":"Br J Haematol"},{"issue":"2","key":"3590_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1365-2141.2008.07417.x","volume":"144","author":"CJ Harrison","year":"2009","unstructured":"Harrison CJ (2009) Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia. Br J Haematol 144(2):147\u2013156. \n                    https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07417.x","journal-title":"Br J Haematol"},{"key":"3590_CR12","doi-asserted-by":"publisher","unstructured":"Lafage-Pochitaloff M, Baranger L, Hunault M et al (2017) Value of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia. Blood. \n                    https:\/\/doi.org\/10.1182\/blood-2017-05-783852","DOI":"10.1182\/blood-2017-05-783852"},{"key":"3590_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08880018.2014.960119","volume":"32","author":"W Liu","year":"2015","unstructured":"Liu W, Hu S, Konopleva M, Khoury JD, Kalhor N, Tang G, Bueso-Ramos CE, Jorgensen JL, Lin P, Medeiros LJ, Lu X (2015) De novo MYC and BCL2 double-hit B-cell precursor acute lymphoblastic leukemia (BCP-ALL) in pediatric and young adult patients associated with poor prognosis. Pediatr Hematol Oncol 32:1\u201313. \n                    https:\/\/doi.org\/10.3109\/08880018.2015.1087611","journal-title":"Pediatr Hematol Oncol"},{"key":"3590_CR14","doi-asserted-by":"crossref","unstructured":"Marosi C, Bettelheim P, Chott A et al. (1992) Simultaneous occurrence of t(14;18) and t(8;22) common acute lymphoblastic leukemia. Ann Hematol 64(2):101\u2013104","DOI":"10.1007\/BF01715354"},{"key":"3590_CR15","doi-asserted-by":"publisher","unstructured":"D'Achille P, Seymour JF, Campbell LJ (2006) Translocation (14;18)(q32;q21) in acute lymphoblastic leukemia: a study of 12 cases and review of the literature. Cancer Genet Cytogenet 171(1):52\u201356. \n                    https:\/\/doi.org\/10.1016\/j.cancergencyto.2006.07.005","DOI":"10.1016\/j.cancergencyto.2006.07.005"},{"key":"3590_CR16","doi-asserted-by":"publisher","unstructured":"Subramaniyam S, Fraser CR, Rao PH et al. (2011) De novo B lymphoblastic leukemia\/lymphoma in an adult with t(14;18)(q32;q21) and c-MYC gene rearrangement involving 10p13. Leuk Lymphoma 52(11):2195\u20132199. \n                    https:\/\/doi.org\/10.3109\/10428194.2011.589548","DOI":"10.3109\/10428194.2011.589548"},{"key":"3590_CR17","doi-asserted-by":"crossref","unstructured":"Nacheva E, Dyer MJ, Fischer P et al. (1993) C-MYC translocations in de novo B-cell lineage acute leukemias with t(14;18)(cell lines Karpas 231 and 353). Blood 82(1):231\u2013240","DOI":"10.1182\/blood.V82.1.231.bloodjournal821231"},{"key":"3590_CR18","doi-asserted-by":"crossref","unstructured":"Mufti GJ, Hamblin TJ, Oscier DG et al. (1983) Common ALL with pre-B-cell features showing (8;14) and (14;18) chromosome translocations. Blood 62(5):1142\u20131146","DOI":"10.1182\/blood.V62.5.1142.1142"},{"issue":"2","key":"3590_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.11406\/rinketsu.58.143","volume":"58","author":"S Uemura","year":"2017","unstructured":"Uemura S, Hasegawa D, Yokoi T, Nino N, Tahara T, Tamura A, Saito A, Kozaki A, Kishimoto K, Ishida T, Kawasaki K, Yamamoto N, Mori T, Nishimura N, Kosaka Y (2017) Refractory double-hit lymphoma\/leukemia in childhood mimicking B-precursor acute lymphoblastic leukemia at initial presentation. Rinsho ketsueki 58(2):143\u2013149. \n                    https:\/\/doi.org\/10.11406\/rinketsu.58.143","journal-title":"Rinsho ketsueki"},{"key":"3590_CR20","doi-asserted-by":"crossref","unstructured":"Pegoraro L, Palumbo A, Erikson J et al. (1984) A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia. Proc Natl Acad Sci USA 81(22):7166\u20137170","DOI":"10.1073\/pnas.81.22.7166"},{"issue":"9","key":"3590_CR21","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1182\/blood-2011-09-377713","volume":"120","author":"N G\u00f6kbuget","year":"2012","unstructured":"G\u00f6kbuget N, Kneba M, Raff T et al (2012) Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies. Blood 120(9):1868\u20131876. \n                    https:\/\/doi.org\/10.1182\/blood-2011-09-377713","journal-title":"Blood"},{"issue":"26","key":"3590_CR22","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1182\/blood-2014-03-563627","volume":"124","author":"D Hoelzer","year":"2014","unstructured":"Hoelzer D, Walewski J, Dohner H, Viardot A, Hiddemann W, Spiekermann K, Serve H, Duhrsen U, Huttmann A, Thiel E, Dengler J, Kneba M, Schaich M, Schmidt-Wolf IGH, Beck J, Hertenstein B, Reichle A, Domanska-Czyz K, Fietkau R, Horst HA, Rieder H, Schwartz S, Burmeister T, Gokbuget N, for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia (2014) Improved outcome of adult Burkitt lymphoma\/leukemia with rituximab and chemotherapy. Report of a large prospective multicenter trial. Blood 124(26):3870\u20133879. \n                    https:\/\/doi.org\/10.1182\/blood-2014-03-563627","journal-title":"Blood"},{"issue":"3","key":"3590_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/PAS.0b013e3181cd3aeb","volume":"34","author":"M Snuderl","year":"2010","unstructured":"Snuderl M, Kolman OK, Chen Y-B, Hsu JJ, Ackerman AM, Cin PD, Ferry JA, Harris NL, Hasserjian RP, Zukerberg LR, Abramson JS, Hochberg EP, Lee H, Lee AI, Toomey CE, Sohani AR (2010) B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Am J Surg Pathol 34(3):327\u2013340. \n                    https:\/\/doi.org\/10.1097\/PAS.0b013e3181cd3aeb","journal-title":"Am J Surg Pathol"},{"issue":"15","key":"3590_CR24","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1182\/blood-2014-05-578963","volume":"124","author":"AM Petrich","year":"2014","unstructured":"Petrich AM, Gandhi M, Jovanovic B, Castillo JJ, Rajguru S, Yang DT, Shah KA, Whyman JD, Lansigan F, Hernandez-Ilizaliturri FJ, Lee LX, Barta SK, Melinamani S, Karmali R, Adeimy C, Smith S, Dalal N, Nabhan C, Peace D, Vose J, Evens AM, Shah N, Fenske TS, Zelenetz AD, Landsburg DJ, Howlett C, Mato A, Jaglal M, Chavez JC, Tsai JP, Reddy N, Li S, Handler C, Flowers CR, Cohen JB, Blum KA, Song K, Sun H, Press O, Cassaday R, Jaso J, Medeiros LJ, Sohani AR, Abramson JS (2014) Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma. A multicenter retrospective analysis. Blood 124(15):2354\u20132361. \n                    https:\/\/doi.org\/10.1182\/blood-2014-05-578963","journal-title":"Blood"},{"issue":"1","key":"3590_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/modpathol.2011.147","volume":"25","author":"S Li","year":"2012","unstructured":"Li S, Lin P, Fayad LE, Lennon PA, Miranda RN, Yin CC, Lin E, Medeiros LJ (2012) B-cell lymphomas with MYC\/8q24 rearrangements and IGH@BCL2\/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome. Mod Pathol 25(1):145\u2013156. \n                    https:\/\/doi.org\/10.1038\/modpathol.2011.147","journal-title":"Mod Pathol"},{"issue":"20","key":"3590_CR26","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1200\/JCO.2017.72.2157","volume":"35","author":"DJ Landsburg","year":"2017","unstructured":"Landsburg DJ, Falkiewicz MK, Maly J, Blum KA, Howlett C, Feldman T, Mato AR, Hill BT, Li S, Medeiros LJ, Torka P, Hernandez-Ilizaliturri F, Reddy NM, Singavi A, Fenske TS, Chavez JC, Kaplan JB, Behdad A, Petrich AM, Bast MA, Vose JM, Olszewski AJ, Costa C, Lansigan F, Gerson JN, Barta SK, Calzada O, Cohen JB, Lue JK, Amengual JE, Rivera X, Persky DO, Peace DJ, Nathan S, Cassaday RD (2017) Outcomes of patients with double-hit lymphoma who achieve first complete remission. J Clin Oncol Off J Am Soc Clin Oncol 35(20):2260\u20132267. \n                    https:\/\/doi.org\/10.1200\/JCO.2017.72.2157","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"10","key":"3590_CR27","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1182\/blood-2011-12-399287","volume":"120","author":"N Gokbuget","year":"2012","unstructured":"Gokbuget N, Stanze D, Beck J, Diedrich H, Horst HA, Huttmann A, Kobbe G, Kreuzer KA, Leimer L, Reichle A, Schaich M, Schwartz S, Serve H, Starck M, Stelljes M, Stuhlmann R, Viardot A, Wendelin K, Freund M, Hoelzer D, on behalf of the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia (2012) Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation. Blood 120(10):2032\u20132041. \n                    https:\/\/doi.org\/10.1182\/blood-2011-12-399287","journal-title":"Blood"},{"issue":"3","key":"3590_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/PAS.0b013e31826cebad","volume":"37","author":"RK Pillai","year":"2013","unstructured":"Pillai RK, Sathanoori M, van Oss SB, Swerdlow SH (2013) Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas. Am J Surg Pathol 37(3):323\u2013332. \n                    https:\/\/doi.org\/10.1097\/PAS.0b013e31826cebad","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"3590_CR29","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1182\/blood-2006-05-018192","volume":"109","author":"AK Fielding","year":"2007","unstructured":"Fielding AK, Richards SM, Chopra R, Lazarus HM, Litzow MR, Buck G, Durrant IJ, Luger SM, Marks DI, Franklin IM, McMillan AK, Tallman MS, Rowe JM, Goldstone AH, Medical Research Council of the United Kingdom Adult ALL Working Party and the Eastern Cooperative Oncology Group (2007) Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12\/ECOG 2993 study. Blood 109(3):944\u2013950. \n                    https:\/\/doi.org\/10.1182\/blood-2006-05-018192","journal-title":"Blood"},{"issue":"12","key":"3590_CR30","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.3324\/haematol.2016.144311","volume":"101","author":"N G\u00f6kbuget","year":"2016","unstructured":"G\u00f6kbuget N, Dombret H, Ribera J-M et al (2016) International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed\/refractory acute lymphoblastic leukemia. Haematologica 101(12):1524\u20131533. \n                    https:\/\/doi.org\/10.3324\/haematol.2016.144311","journal-title":"Haematologica"},{"key":"3590_CR31","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3324\/haematol.2018.190157","volume":"103","author":"ED McPhail","year":"2018","unstructured":"McPhail ED, Maurer MJ, Macon WR et al (2018) Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements is not associated with MYC\/IG gene rearrangements. Haematologica 103:1899\u20131907. \n                    https:\/\/doi.org\/10.3324\/haematol.2018.190157","journal-title":"Haematologica"},{"issue":"1","key":"3590_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1200\/JCO.2016.68.2740","volume":"35","author":"AF Herrera","year":"2017","unstructured":"Herrera AF, Mei M, Low L, Kim HT, Griffin GK, Song JY, Merryman RW, Bedell V, Pak C, Sun H, Paris T, Stiller T, Brown JR, Budde LE, Chan WC, Chen R, Davids MS, Freedman AS, Fisher DC, Jacobsen ED, Jacobson CA, LaCasce AS, Murata-Collins J, Nademanee AP, Palmer JM, Pihan GA, Pillai R, Popplewell L, Siddiqi T, Sohani AR, Zain J, Rosen ST, Kwak LW, Weinstock DM, Forman SJ, Weisenburger DD, Kim Y, Rodig SJ, Krishnan A, Armand P (2017) Relapsed or refractory double-Expressor and double-hit lymphomas have inferior progression-free survival after autologous stem-cell transplantation. J Clin Oncol Off J Am Soc Clin Oncol 35(1):24\u201331. \n                    https:\/\/doi.org\/10.1200\/JCO.2016.68.2740","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"3590_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10428194.2017.1406085","volume":"59","author":"AI Chen","year":"2017","unstructured":"Chen AI, Leonard JT, Okada CY, Gay ND, Chansky K, Fan G, Dunlap JB, Raess PW, Braziel RM, Stentz A, Maziarz RT (2017) Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphoma. Leuk Lymphoma 59:1\u20136. \n                    https:\/\/doi.org\/10.1080\/10428194.2017.1406085","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"3590_CR34","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/ejh.12212","volume":"92","author":"MO Pedersen","year":"2014","unstructured":"Pedersen MO, Gang AO, Poulsen TS, Knudsen H, Lauritzen AF, Nielsen SL, Klausen TW, N\u00f8rgaard P (2014) MYC translocation partner gene determines survival of patients with large B-cell lymphoma with MYC- or double-hit MYC\/BCL2 translocations. Eur J Haematol 92(1):42\u201348. \n                    https:\/\/doi.org\/10.1111\/ejh.12212","journal-title":"Eur J Haematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-03590-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-03590-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-03590-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,5]],"date-time":"2020-01-05T19:10:29Z","timestamp":1578251429000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-03590-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,6]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["3590"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-03590-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,6]]},"assertion":[{"value":"7 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures performed in studies involving human participants with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Prof. Haferlach reports reimbursements for diagnostic services from the MLL Munich Leukemia Laboratory during the conduct of this study; and being a part owner of the MLL Munich Leukemia Laboratory; The other authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures of conflict of interest"}}]}}